Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2016-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16dce232df7bc9209b02d8085398d29c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b0a420f86d275ff22df8cc05ac27816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10e2af9c9a1e669fdba05ab2bff4e29e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828b96459dad03fb4d5670e51f0fd2b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beadccbc2759b3a7e30eda2d7ae2bbb3 |
publicationDate |
2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016203426-A1 |
titleOfInvention |
Bilayer tablet formulations |
abstract |
A coated tablet that comprises: (1) a tablet core comprising metformin; (2) a first coating that coats the tablet core and optionally comprises saxagliptin; (3) a second coating 5 that coats the first coating and optionally comprises saxagliptin; and (4) optionally a third coating that coats the second coating; wherein at least one of the first coating and the second coating comprises saxagliptin. |
priorityDate |
2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |